in

FDA in ‘ongoing’ talks with Gilead to make remdesivir available to coronavirus patients ‘as quickly as possible’

The Food and Drug Administration has been in “sustained and ongoing” discussions with Gilead Sciences to make antiviral drug remdesivir available to Covid-19 patients “as quickly as possible, as appropriate,” the agency said.

Exclusive: Brazil, automakers deadlocked over loan collateral from parent companies – sources

Fed pledges to keep rates near zero until full employment, inflation come back